Cardio Diagnostics (CDIO) Projected to Post Quarterly Earnings on Wednesday

Cardio Diagnostics (NASDAQ:CDIO) will likely be releasing its earnings data before the market opens on Wednesday, May 14th. Analysts expect Cardio Diagnostics to post earnings of ($0.06) per share and revenue of $0.05 million for the quarter.

Cardio Diagnostics Trading Down 15.0%

NASDAQ CDIO opened at $0.16 on Tuesday. Cardio Diagnostics has a twelve month low of $4.50 and a twelve month high of $53.10. The firm has a 50-day simple moving average of $0.39 and a 200 day simple moving average of $0.51.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.